RE:RE:What do we need- 35 patients?
PezDalatoYou wrote: I don't get the DIMI delay(s) for a number of reasons: 1. Dialysis sucks. As someone who has seen first hand what a dialysis clinic is like...a patient stuck in there would almost kill for a chance to get out and have their treatment at home. Finding 35 patients to volunteer should not be a problem. Taping a 'volunteers wanted' sign to the clinic door will move this forward faster. 2. A company like DaVi should be rolling out the red carpet and giving top priority to move the Dimi approval process forward...as a high corporate directive. It is in their own best interest. 3. Kellum knows all of this intimately. The remaining contents of the NR are just puzzle pieces ready to be placed, IMHO. Maybe the ease of where/when the DIMI trial can take place is the clue. ; - )
I like this post Pez and the last sentence.
The failure to move either Trial forward SEEMS LIKE it MUST BE a big clue in and of itself.
Maybe we need to ask, who & how someone benefits from stalling BOTH Trials, plus a delay on a spin off, plus a delay on laying the groundwork for US investor demand?
Besides two Trials stalled, delayed or, moving at a snails pace, we have:
-Very little engagement with investment community
-when done, it's done poorly at bad times with pretty much zero results
- lowest level of US listing, no news flow
- US IR MIA
- plans to disclose US listing plans continue to be pushed ahead
- the last two consecutive financings were supposed to have gone to US institutions ( the first was supposed to be 11 "institutions", the second all taken up by AGP )
- no AGP Analyst Report yet
- a Dialco spin-off has been MIA for > 1 year
- dismissal or avoidance of the PMX for COVID discussion
- Baxter seems to have a ROFR on PMX distribution with a competing/ complimentary? product
- Baxter has expressed an interest in the past in getting back into the HD market
Before Gm dismisses this all as simply a lifestyle play , or gross mismgt. MAKE NO MISTAKE this is still a $2B to $5B opportunity AND THEY KNOW IT!
IMO it's time for Mgt to disclose the real plan/ endgame to ALL shareholders.
Is it to be listed on Nasdaq with accompanying value discovery (share appreciation) over time? or NOT?
The current set of circumstances and excuses no longer pass the smell test.
MM